Lv72
3660 积分 2021-03-17 加入
Clinical toxicity of antibody drug conjugates: a meta-analysis of payloads
4天前
已完结
Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
6天前
已完结
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
6天前
已完结
A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
12天前
已完结
Topoisomerase I inhibitors: camptothecins and beyond
13天前
已完结
Factors Involved in the Design of Cytotoxic Payloads for Antibody–Drug Conjugates
14天前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
21天前
已完结
Strategies and challenges for the next generation of antibody–drug conjugates
1个月前
已完结
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
1个月前
已完结
皖公网安备34019202002308
